Publication:
Oral methotrexate in the treatment of Hailey‒Hailey disease: a case report

dc.contributor.authorMaširević Mudrić, Iva (59065066300)
dc.contributor.authorPelemiš, Jovana (59063672100)
dc.contributor.authorLekić, Branislav (56092444000)
dc.contributor.authorPopadić, Svetlana (24830928800)
dc.date.accessioned2025-06-12T11:42:57Z
dc.date.available2025-06-12T11:42:57Z
dc.date.issued2024
dc.description.abstractHailey‒Hailey disease is a rare chronic autosomal-dominant blistering disease characterized by erosions, fissures, and vegetations occurring in intertriginous regions. To date, there is no specific treatment and there are no therapeutic guidelines, which makes management of the disease challenging. We present the case of a 43-year-old man unsuccessfully treated for Hailey‒Hailey disease with topical and systemic corticosteroids, antibiotics, and surgical debridement. At presentation he had erosions, vegetations, and infection in the axillae and groin. We introduced oral methotrexate, 10 mg weekly, and complete remission was achieved in 3 weeks. After 8 weeks, we decided to discontinue methotrexate due to lesion absence. Over 3 years of follow-up, mild flares were effectively managed with topical miconazole or mild steroid creams. We conclude that oral methotrexate is safe and effective for achieving long-term remission in Hailey‒Hailey disease.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85192303653&partnerID=40&md5=c5f83252e68db9f1d2030dca10e29dee
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/1080
dc.titleOral methotrexate in the treatment of Hailey‒Hailey disease: a case report
dspace.entity.typePublication

Files